China Molecular Diagnostics Market, Test Volume & Forecast: by Oncology Test (Breast Cancer, Colorectal Cancer, and Prostate Cancer) Infectious Disease Test (Virology and HPV), and Genetic Test (Blood Screening and HLA)

  • ID: 4384120
  • Report
  • Region: China
  • 105 Pages
  • Renub Research
1 of 4
China Molecular Diagnostics Market is Expected to Be More Than USD 1.5 Billion by the Year 2022

FEATURED COMPANIES

  • BGI-Shenzhen
  • OriGene Technologies
  • MORE

China molecular diagnostics market is expected to be more than USD 1.5 Billion by the year 2022. As a part of the evolution of medicine in China; en route for targeted therapy and recognizing the revenue as well as profits in this new market, Diagnostics instruments are the foundation of the biotechnology industry and the pharmaceutical industry are appropriately important in molecular diagnostics.
 
The molecular diagnostics market is propelled by technologies advancement from the Diagnostics instruments. Capitalizing on the growth opportunity requires considerable modifications to accessible commercialization structures, and capabilities that are frequently more appropriate in helping commercial R&D consumers and intellectual laboratories.

Diagnostics device companies are in view of the way into the molecular diagnostics market or in being collaboration for years. Most of the Diagnostics instrument companies have not previously needed to develop the level of commercial capabilities required in the molecular diagnostics market. The major challenge for diagnostic companies is to understand and manage the troubles.

Rising incidence of infectious diseases along with cancer cases and the rise of the private healthcare sector in China, with the development of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region are some of the contributors which are expected to drive the molecular diagnostics market over the projection period.

China Molecular Diagnostic Market

China molecular diagnostics market is distinguished into three main categories: Oncology Test, Infectious Disease Test and Genetic Disease Test. Further, Oncology Test has been categorized into three main types: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing. Infectious Disease Test has been categorized into two main types, namely, virology and HPV and Genetic Test has been categorized into Blood Screening and HLA.

China Molecular Diagnostic Market Share Analysis

According to research, Virology tests lead the market share of China Infectious Disease test market. Blood screening dominates the market share of Genetics test market. Our analysis found that nearly 300 million molecular diagnostic tests will be performed in China by the end of 2022 of which Virology accounts for one of the most performed tests segments.

Key Players in China Molecular Diagnostics Market

This report covers the players and in depth analysis of these players, the players who played a very crucial role in the development of molecular diagnostics were Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories (Privately held), Guangzhou Kingmed Diagnostics Center Co. Ltd, Kindstar Global (Privately held), BGI-Shenzhen, and OriGene Technologies.

This is the 5th report on the Molecular Diagnostics industry. China Molecular Diagnostics Market, Test Volume & Forecast: by Oncology Test (Breast Cancer, Colorectal Cancer, and Prostate Cancer) Infectious Disease Test (Virology and HPV), Genetic Test (Blood Screening and HLA) provides a comprehensive assessment of the fast-evolving, high-growth China Molecular diagnostics market.

This 105 page report with 55 Figures and 14 Tables studies the China Molecular Diagnostic market from 4 view points:

1. Market & Forecast
2. Molecular Diagnostics Segments Market & Forecast
3. Molecular Diagnostics Segments Test Volume & Forecast
4. Profiles of Select Private Clinical Labs & Diagnostic Services Companies
 
Segments Covered in this report are as follows:

Oncology Test Market and Volume:

  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer

Infectious Disease Test Market and Volume:

  • Virology
  • HPV

Genetic Test Market and Volume:

  • Blood Screening
  • HLA

Key Players Analysis:

  • Zhejiang Di’an Diagnostics Technology Co. Ltd.
  • ADICON Clinical Laboratories (Privately held)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen
  • OriGene Technologies

Key Questions Answered in this Study:

  • What is China molecular diagnostics market size from 2011 to 2022?
  • What is China molecular diagnostics tests volume from 2011 to 2022?
  • What are China molecular diagnostics segments market & Forecast?
  • What are the growth drivers of Molecular diagnostics in China?
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BGI-Shenzhen
  • OriGene Technologies
  • MORE

1 Research Findings

2 China Molecular Diagnostic Market & Test Volume Forecast
2.1 China Molecular Diagnostic Market
2.2 China Molecular Diagnostic Test Volume

3 China Molecular Diagnostic Market Share Analysis
3.1 Market Share - (Oncology, Infectious, Genetic) Testing
3.2 Market Share - Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

4 China Molecular Diagnostic Volume Share (2011 - 2022)
4.1 Volume Share - (Oncology, Infectious, Genetic) Testing
4.2 Volume Share - Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

5 Segments Test Volume - China Molecular Diagnostics
5.1 Volume Share - (Breast, Colorectal, Prostate) Oncology Test
5.2 Oncology Test Volume
5.2.1 Breast Cancer Test Volume
5.2.2 Colorectal Cancer Test Volume
5.2.3 Prostate Cancer Test Volume
5.3 Volume Share - (Virology, HPV) Infectious Disease Test
5.4 Infectious Disease Test Volume
5.4.1 Virology Test Volume
5.4.2 HPV Test Volume
5.5 Volume Share - (Blood Screening, HLA) Genetic Test
5.6 Genetic Test Volume
5.6.1 Blood Screening Test Volume
5.6.2 HLA Test Volume

6 Segments Test Market - China Molecular Diagnostics Market (2011 - 2022)
6.1 Market Share - (Breast, Colorectal, Prostate) Oncology Test
6.2 Oncology Test Market
6.2.1 Breast Cancer Test Market
6.2.2 Colorectal Cancer Test Market
6.2.3 Prostate Cancer Test Market
6.3 Market Share - (Virology, HPV) Infectious Disease Test
6.4 Infectious Disease Test Market
6.4.1 Virology Test Market
6.4.2 HPV Test Market
6.5 Market Share - (Blood Screening, HLA) Genetic Test
6.6 Genetic Test Market
6.6.1 Blood Screening Market
6.6.2 HLA Test Market

7 China Healthcare Insurance Schemes
7.1 China Healthcare Insurance Schemes
7.1.1 NRCMS
7.1.2 UEBMI
7.1.3 URBMI
7.1.4 Private Health Insurance
7.1.5 Cost-sharing and out-of-pocket Spending

8 Growth Drivers
8.1 Rising Order for High Quality Healthcare Products
8.2 Growing Cases of Lifestyle Diseases
8.3 Rapid Diagnosis of Infectious Diseases
8.4 Rise in Number of Private Hospitals & Independent Diagnostics Clinics
8.4.1 Rise in the Number of Hospital Beds across all Medical Institutions
8.5 Increasing Automation

9 Challenges
9.1 Nil Government Support & Public Awareness
9.2 Dearth of Trained Medical Technicians
9.3 Reimbursement Rates differ from Province to Province in China
9.3.1 Chinese Government Regulating Laboratory Testing in China

10 Profiles of Select Private Clinical Labs and Diagnostic Services Companies
10.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
10.1.1 Company Overview
10.1.2 Products and Services Offered by Di’an
10.2 ADICON Clinical Laboratories (Privately held)
10.2.1 Company Overview
10.2.2 Products and Services Offered by ADICON
10.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
10.3.1 Company Overview
10.3.2 Products and Services Offered by Kingmed
10.4 Kindstar Global (Privately held)
10.4.1 Company Overview
10.4.2 Products and Services Offered by Kindstar
10.5 BGI-Shenzhen
10.5.1 Company Overview
10.5.2 BGI’s Innovative Approach
10.6 OriGene Technologies
10.6.1 Company Overview
10.6.2 Products and Services Offered by OriGene

List of Figures
Figure 2-1: China - Molecular Diagnostic Market (Million US$), 2011 - 2016
Figure 2-2: China - Forecast for Molecular Diagnostic Market (Million US$), 2017 - 2022
Figure 2-3: China - Molecular Diagnostic Test Volume (Million), 2011 - 2016
Figure 2-4: China - Forecast for Molecular Diagnostic Test Volume (Million), 2017 - 2022
Figure 3-1: China - Molecular Diagnostic Market Share (Percent), 2011 - 2016
Figure 3-2: China - Forecast for Molecular Diagnostic Market Share (Percent), 2017 - 2022
Figure 3-5: China - Molecular Diagnostic Test Volume Share (Percent), 2011 - 2016
Figure 3-6: China - Forecast for Molecular Diagnostic Test Volume Share (Percent), 2017 - 2022
Figure 4-1: China - Molecular Oncology Test Volume Share (Percent), 2011 - 2016
Figure 4-2: China - Forecast for Molecular Oncology Test Volume Share (Percent), 2017 - 2022
Figure 4-3: Rural China - Cancer Screening Sites by Cancer Type (Number), 2013
Figure 4-4: China - Oncology Test Volume (Million), 2011 - 2016
Figure 4-5: China - Forecast for Oncology Test Volume (Million), 2017 - 2022
Figure 4-6: China - Breast Cancer Molecular Test Volume (Million), 2011 - 2016
Figure 4-7: China - Forecast for Breast Cancer Molecular Test Volume (Million), 2017 - 2022
Figure 4-8: China - Colorectal Cancer Test Volume (Million), 2011 - 2016
Figure 4-9: China - Forecast for Colorectal Cancer Test Volume (Million), 2017 - 2022
Figure 4-10: China - Prostate Cancer Test Volume (Million), 2011 - 2016
Figure 4-11: China - Forecast for Prostate Cancer Test Volume (Million), 2017 - 2022
Figure 4-14: China - Infectious Disease Test Volume (Million), 2011 - 2016
Figure 4-15: China - Forecast for Infectious Disease Test Volume (Million), 2017 - 2022
Figure 4-16: China - Virology Test Volume (Million), 2011 - 2016
Figure 4-17: China - Forecast for Virology Test Volume (Million), 2017 - 2022
Figure 4-18: China - HPV Test Volume (Thousand), 2011 - 2016
Figure 4-19: China - Forecast for HPV Test Volume (Thousand), 2017 - 2022
Figure 4-22: China - Genetic Test Volume (Million), 2011 - 2016
Figure 4-23: China - Forecast for Genetic Test Volume (Million), 2017 - 2022
Figure 4-24: China - Blood Screening Test Volume (Million), 2011 - 2016
Figure 4-25: China - Forecast for Blood Screening Test Volume (Million), 2017 - 2022
Figure 4-26: China - HLA Test Volume (Thousand), 2011 - 2016
Figure 4-27: China - Forecast for HLA Test Volume (Thousand), 2017 - 2022
Figure 5-1: China - Molecular Oncology Test Market Share (Percent), 2011 - 2016
Figure 5-2: China - Forecast for Molecular Oncology Test Market Share (Percent), 2017 - 2022
Figure 5-3: China - Oncology Test Market (Million US$), 2011 - 2016
Figure 5-4: China - Forecast for Oncology Test Market (Million US$), 2017 - 2022
Figure 5-5: China - Breast Cancer Test Market (Million US$), 2011 - 2016
Figure 5-6: China - Forecast for Breast Cancer Test Market (Million US$), 2017 - 2022
Figure 5-7: China - Colorectal Cancer Test Market (Million US$), 2011 - 2016
Figure 5-8: China - Forecast for Colorectal Cancer Test Market (Million US$), 2017 - 2022
Figure 5-9: China - Prostate Cancer Testing Market (Million US$), 2011 - 2016
Figure 5-10: China - Forecast for Prostate Cancer Testing Market (Million US$), 2017 - 2022
Figure 5-13: China - Infectious Disease Test Market (Million US$), 2011 - 2016
Figure 5-14: China - Forecast for Infectious Disease Test Market (Million US$), 2017 - 2022
Figure 5-15: China - Virology Test Market (Million US$), 2011 - 2016
Figure 5-16: China - Forecast for Virology Test Market (Million US$), 2017 - 2022
Figure 5-17: China - HPV Test Market (Million US$), 2011 - 2016
Figure 5-18: China - Forecast for HPV Test Market (Million US$), 2017 - 2022
Figure 5-21: China - Genetic Testing Market (Million US$), 2011 - 2016
Figure 5-22: China - Forecast for Genetic Testing Market (Million US$), 2017 - 2022
Figure 5-23: China - Blood Screening Market (Million US$), 2011 - 2016
Figure 5-24: China - Forecast for Blood Screening Market (Million US$), 2017 - 2022
Figure 5-25: China - HLA Test Market (Thousand US$), 2011 - 2016
Figure 5-26: China - Forecast for HLA Test Market (Thousand US$), 2017 - 2022
Figure 6-1: China - Healthcare Spending (Billion US$), 2011 &2020
Figure 8-1: Kindstar - Collaboration with Hospitals in China (Number), 2006-2012

List of Tables
Table 3-1: China - Molecular Diagnostic Application Market Share (Percent), 2011 - 2016
Table 3-2: China - Forecast for Molecular Diagnostic Application Market Share (Percent), 2017 - 2022
Table 3-3: China - Molecular Diagnostic Test Volume Application Share (Percent), 2011 - 2016
Table 3-4: China - Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2017 - 2022
Table 4-1: China - Molecular Infectious Disease Test Volume Share (Percent), 2011 - 2016
Table 4-2: China - Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2017 - 2022
Table 4-3: China - Molecular Genetic Test Volume Share (Percent), 2011 - 2016
Table 4-4: China - Forecast for Molecular Genetic Test Volume Share (Percent), 2017 - 2022
Table 5-1: China - Molecular Infectious Disease Test Market Share (Percent), 2011 - 2016
Table 5-2: China - Forecast for Molecular Infectious Disease Test Market Share (Percent), 2017 - 2022
Table 5-3: China - Molecular Genetic Test Market Share (Percent), 2011 - 2016
Table 5-4: China - Forecast for Molecular Genetic Test Market Share (Percent), 2017 - 2022
Table 6-1: China - Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
Table 8-1: Number of Hospital Beds for every 1,000 people

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ADICON Clinical Laboratories (Privately held)
  • BGI-Shenzhen
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • OriGene Technologies
  • Zhejiang Di’an Diagnostics Technology Co. Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll